Divya Bajpai,Cristina Popa,Prasoon Verma et al.
Divya Bajpai et al.
Hypertensive disorders of pregnancy complicate up to 10% of pregnancies and remain the major cause of maternal and neonatal morbidity and mortality. Hypertensive disorders of pregnancy can be classified into four groups depending on the ons...
Andreia F Curto,Anna E Lima,Miguel Verdelho
Andreia F Curto
An Unexpected Finding in a Patient with AKI, Nephrotic Range Proteinuria, and MGUS [0.03%]
AKI、肾病范围蛋白尿和MGUS患者的意外发现
Florian G Scurt,Maximilian J Ganz,Christos Chatzikyrkou
Florian G Scurt
Kana N Miyata,Cynthia C Nast
Kana N Miyata
Sunil Bhandari
Sunil Bhandari
How Sweet It Is: A Perspective on the Potential Anti-Tumor Role for SGLT2 Inhibitors [0.03%]
天赐良药：钠-葡萄糖协同转运蛋白2抑制剂的潜在抗肿瘤作用展望
Deepthi Gunasekaran,Anushree C Shirali
Deepthi Gunasekaran
Correlates of Rates and Treatment Readiness for Depressive Symptoms, Pain, and Fatigue in Hemodialysis Patients: Results from the TĀCcare Study [0.03%]
透析患者抑郁、疼痛和疲劳症状的发生率及治疗意愿的相关因素：TĀCcare研究结果
Susan M Devaraj,Maria-Eleni Roumelioti,Jonathan G Yabes et al.
Susan M Devaraj et al.
Key Points: Lower neighborhood walkability was associated with higher depressive symptoms and fatigue and younger age with depressive symptoms.Depressive symptoms, pain, and fatigue were frequently reported, often occurr...
John Pell,Soichiro Nagata,Madhav C Menon
John Pell
Since the seminal discovery of the trypanolytic, exonic variants in apolipoprotein L1 (APOL1) and their association with kidney disease in individuals of recent African ancestry, a wide body of research has emerged offering key insights int...
Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases [0.03%]
心血管-肾脏-代谢性疾病的发展及合并带来的医疗成本分析
Gregory A Nichols,Efrat L Amitay,Satabdi Chatterjee et al.
Gregory A Nichols et al.
Key Points: Onset of any new cardio-renal-metabolic condition drove substantial increase in health care costs.Overall costs increased by $10,316 (130%) when CKD developed, $6789 (84%) for type 2 diabetes, $21,573 (304%) ...
Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma [0.03%]
移植物抗宿主病后噬神经细胞肉瘤的病例报告：一名患者的治疗经历从化疗到同种异体造血干细胞移植和免疫检查点抑制剂治疗无效再到最终使用伊布替尼实现持续缓解
Gabrielle Côté,Husam Alqaisi,Christopher T Chan et al.
Gabrielle Côté et al.
Key Points: Many patients with metastatic urothelial carcinoma are deemed cisplatin-ineligible because of reduced kidney function. Options include split-dose cisplatin or carboplatin.There was no significant association ...
Comparative Study
Kidney360. 2023 Sep 1;4(9):e1203-e1211. DOI:10.34067/KID.0000000000000214 2023